【ＰＤＦ作成用】平成23年度共同研究成果報告書.ren

取扱説明書

ED-601 ED-501 ED-401 2 3 4 23 14 5 6 18 10 7 1 2 6 3 4 8 9 16 16 16 12 1 2 18 10 2 1 5 12 11 1 2 1 2 12 1 2 13 16 14 3 2 4 1 1 2 16 3 4 18 15 1 2 16 2 3 1 1 2 3 18 17 18 22 19 D A C 20 A B 22 B C D 22

技報65

untitled

METAL FORM METAL FORM METAL FORM METAL FORM METAL FORM METAL FORM METAL FORM METAL FORM METAL FORM METAL FORM METAL FORM METAL FORM 01 METAL FORM METAL FORM 02 03 METAL FORM 04 METAL FORM METAL FORM METAL

H

1

1 1 2 2 3 4 5 5 6 7 8 10 9 10 10 10 11 13 14 15 15 16 17 18 19 21 21 22 22 24 28 38 40 41 41 43 45 46 47 47 47 47 48 50 50 50 50 51 52 54 54 55 56 56 57 57 57 58 58 59 59 59 61 61 61 62 62 62 62 63 63

28 3 21 7 10 22 2 2

28 10 2 () 1 28 3 21 7 10 22 2 2 28 1. 2. () 28 6 29 11 3. 4. 5. ) 6. 7. 3 28 5 IC 28 5 28 6 1.5 2 28 7 1 28 9 28 9. OK 7 28 14 28 15 28 22 22 7 10 200 2 22 10 9 100 23 2 12 100 FAX 1 2 TEL FAX 16 28 20

untitled

3 m/sec 8.35 39.06 3.22 2.15 13.72 52.78 15.00 2.12 2.69 12.62 27.62 3 m/ 772 79 68 263 410 1,182 3 m/sec 3.87 0.63 8.00 3.12 1.38 12.50 12.50 2.00 2.50 1.00 5.50 5.50 m/ 105 122 20 247 247 3 m/sec 0.23

untitled

1 4 4 6 8 10 30 13 14 16 16 17 18 19 19 96 21 23 24 3 27 27 4 27 128 24 4 1 50 by ( 30 30 200 30 30 24 4 TOP 10 2012 8 22 3 1 7 1,000 100 30 26 3 140 21 60 98 88,000 96 3 5 29 300 21 21 11 21

1

1 2 1300 3 300 55 300 4 150 1 5 6 7 UFO 8 9 10 11 12 13 14 15 16 17 18 A 100 19 20 20 3 SOS 21 22 23 24 3000 25 26 27 UFO 28 29 30 31 32 10 33 34 35 36 37 38 39 40 41 42 40 43 44 45 46 47 Q&A 48 49 50

1

1 2 1300 3 300 55 300 4 150 1 5 6 7 UFO 8 9 10 11 12 13 14 15 16 17 18 A 100 19 20 20 3 SOS 21 22 23 24 3000 25 26 27 UFO 28 29 30 31 32 10 33 34 35 36 37 38 39 40 41 42 43 40 44 45 46 47 Q&A 48 49 50

hy manual JP

CL-SML008 COPY CO COPY CO COPY CO COPY CO COPY CO COPY CO COPY CO COPY CO Y Y Y Y Y Y Y Y COPY CO COPY CO COPY CO COPY CO COPY CO COPY CO COPY CO COPY CO PY PY PY PY PY PY

( ) ー ( () ) 250 200 150 100 50 0 51 20 54 59 33 35 91 92 93 98 99 94 6 7 7 8 9 11 18 17 18 20 22 23 10 9 8 9 9 9 62 40 66 74 41 47 21 22 23 24 25 26 10 8 6 4 2 0 m3/s 7 41.3 5 5 18.4

GQ0003_17008ohta.indd

Proteome Letters 2017 2 59-66 2017 * *E-mail: shinya.ohta@kochi-u.ac.jp 783-8505 2017 10 2 2017 10 30 2017 11 8 4,000 1 1882 Walther Flemming 1977 Uli Laemmli Chromosome Scaffold 1 DNA IIα TopoIIα Structure

7th埼玉オープン.pm6

6 7 6 7 6-0 6 7 0 6-6 -0 7-0 -7 8 8 - - 9 0 0 - -8 9 0-6 -8 0 8- -7-6 6-0 -7 7 0 8-8 (by Mitsuhashi) 6 0- -8 6 7 8 6 7 9 0-8 8 9 0 7 6 8 9-8 6-8 0 7-7 - 8 9 0 - -0 7 6 6-7 - - - 9- -6 9 0 8-8 -0 - -7-7

untitled

2002 2005 2002 2005 3 2002 ( 14) 8 AVA 5 JAL 6 50 (2002 8 ) 21( ) 17:40(JAL715) 23:30( 6:50) 22 ( ) 23 ( ) 24 ( ) 25 ( ) 0:50(JAL716) 8:35 BMR 1 2 2 250 1,000 3 200 4 ( ) ( ) ( ) ( ) 5 50m 10 6 SOS SOS

NCA1-V6-650 C9A1-V6-650

NCA1-V6-650 C9A1-V6-650 1 2 3 1 1 1 1 1 1 2 c 2 1 c 1 2 1 2 c 3 4 1 2 3 2 1 2 3 4 1 1 1 2 1 2 3 1 1 1 2 1 i u 1 2 3 o u i 4 o 4 5 1 2 o 1 o 1 o o 3 2 1 1 1 1 1 2 3 4 5 6 4 1

OM Z49-A

NCA3 V6 650 C9A3 V6 650 1 2 3 1 1 1 1 2 c 1 1 2 1 2 1 1 c 2 c 3 4 1 2 3 1 2 3 4 1 2 1 1 2 1 3 2 1 1 1 2 1 i u 2 3 o u i 1 4 4 o o 1 o o 1 2 o 3 3 1 2 5 1 1 1 1 1 2 3 4 5 6

1

本文／ＹＡ４１４６Ｄ

C Stensaas, L.J.J. Comp. Neurol.,,. Rakic, P.J. Comp. Neurol.,,. Kawauchi, T. & Hoshino, M.Dev. Neurosci.,,. Kawauchi, T., Chihama, K., Nabeshima, Y., & Hoshino, M. EMBO J.,,. Kawauchi, T., Chihama, K.,

本文／羽田野貴仁（ｐ１１９‐１３６）

平成26年度 化学物質分析法開発報告書

2,2-2,2 -Iminodiethanol Diethanol amine CAS 111-42-2 C 4 H 11 NO 2 105.1356-105.0790-28 C 1) 1.0881 g/cm 3 1)

平成26年度 化学物質分析法開発報告書

2,2-2,2 -Iminodiethanol Diethanol amine CAS 111-42-2 C 4 H 11 NO 2 105.1356-105.0790-28 C 1) 1.0881 g/cm 3 1)

METAL WORLD 2 No 1 2003

No.1 2003 1 METAL WORLD No 1 2003 METAL WORLD 2 No 1 2003 2003No.1 5 11 15 13 21 24 4 METAL WORLD 3 No 1 2003 METAL WORLD 4 No 1 2003 METAL WORLD No 1 2003 5 私はすべてを失った マルヤディ 41 歳 METAL WORLD 7 No 1 2003

0120

文部科学省 科学研究費補助金 新学術領域研究 修飾シグナル病 第二回公開シンポジウム 修飾シグナル病 学術領域の新展開 抄録集 プログラム 2012年1月28日 土 13:00 17:30 東京大学医科学研究所 1号館1F講堂 領域代表者 井上純一郎 2 2012 1 28 13:00-13:10 13:10-15:10 1...2...4...6...8 15:30-17:20 2...10...12...14

本文／ＹＡＹ１４３Ｂ

LC-MS MS LC-MS MS LC-MS MS D-DIGE IMAC D-DIGE p MAP BAG p MAPKAPK Wang D-DIGE D-DIGE ERK MAP ２ ３ ２ ０ 年 ２月 IMAC と２D-DIGE の併用に加えて エストロゲン受容体 バーの消失や細胞運動性の上昇が促されることを明らかに との融合によるキナーゼ活性の操作系とリン酸化モチーフ した７ 一方で一部のヌクレオポリンが有する

60 [] [] 70 24 69 26 26 JETRO 2016 2020 20 150 20 25 15 3 500 6070 2612 H25.10 262 H25.10 271 H25.10 26 21500 23000 25000 35000 35000

Untitled

上原記念生命科学財団研究報告集, 25 (2011) 124. 次世代タンパク質量分析と遺伝学的手法との融合によるクロマチン構造制御による DNA 修復機構の解明 廣田耕志 Key words:dna 修復, プロテオミクス,SILAC, DT40, 遺伝学 京都大学大学院医学研究科放射線遺伝学教室 緒言クロマチン構造は,DNA を規則正しく折り畳み核内にコンパクトに格納する際に重要である. 一方,

05避難シミュレーション編.PDF

1....5-2 1.1...5-2 1.2...5-2 1.3...5-4 1.4...5-5 1.5...5-8 1.6...5-8 1.7...5-9 1.8...5-19 2....5-21 5-1 5-2 ) ( ) / ( ) / ( ) ( 2 ( ) ( ) 5-3 1-1 5-4 ( 17 3 ) 1 ( 1) 1-2 ( )2 3 ( 5 ) 5 1 5 ( ) ( ) 1-2

20 8 27 18 10 28 16 9 29 20 3 14 16 9 30 20 8 27 16 9 29 8 36 21 33 m3 4 3 m3 9m JR 14 1 25 16 3 16 9 30 16 9 29 10 24 1/40 204mm/24h 750m3/s 10m 41 m3 16 9 29 15 16 8 26 16 9 30 16 8 26 16 9 30 41

() 1 1 2 2 3 2 3 308,000 308,000 308,000 199,200 253,000 308,000 77,100 115,200 211,000 308,000 211,200 62,200 185,000 308,000 154,000 308,000 2 () 308,000 308,000 253,000 308,000 77,100 211,000 308,000

1

Microsoft Word - 14_LCMS_アクリルアミド

3--2-3-Iodo-2-propynyl butylcarbamate (IPBC) Carbamic acid, butyl-, 3-iodo-2-propynyl ester Iodocarb CAS 55406-53-6 C 8 H 12 NO 2 I C (g/cm 3 ) (mmhg) log P ow 281.09 (280.9910) 64 68 1.51 1.57 (20 C)

☆H23 13－農薬一斉分析（大垣）.doc

13 56 2011 Examination of Determination of Residual Pesticides in Agricultural Products Yuki OHGAKI, Katsuhiro HAYASHI, Hiroyuki KAWAI, and Kyoko SHIMURA GC/MS 92 LC/MS/MS 60 150 n- 5 GC/MS 92 79 70% LC/MS/MS

testoŁŠ‚¬ŁÏ−·−í…J…^…“…O

gtf Wnt5a-Ror2 IL-8 in vitro Ozony Tron P. gingivalis SOD ELISA Location of main occluding areas and masticatory ability in patients with reduced occlusal support 12-Methacryloyloxydodecylpyridinium bromide

... 1...1...4...4...10...12... 15...15...16...16...16...16...16...16...17... 18...18...21...21...30...36...39...42...44...46...48...50

... 1...1...4...4...10...12... 15...15...16...16...16...16...16...16...17... 18...18...21...21...30...36...39...42...44...46...48...50 ... 51...51...52...52 1 1.1 1 1 2 3 1.2 1.2.1 4 5 6 7 8 9 1.2.2 10

ESL ()-methyl 3-{4-[2-hydroxy-3-(isopropylamino)pro poxy]phenyl} propanoate monohydrochloride H 3 C O O JAN( ) JAN( )esmolol hydrochloride r-inn( )esm

1 186 186 (1) - 192 (2) (ISAintrinsic sympathomimetic activity) 199 (3) ( MSAmembrane stabilizing activity) 2 (4) 21 (5) 212 (6) 216 (7) 219 (8) 224 (9) (ASL-8123) - 229 (1) d-esl l-esl - 231 2 235 235

スライド 1

.A..-.....o.c.....c.p..38.ren

シンポジウム　報告書_5.PDF

... 2... 2... 2... 2... 2... 3... 3... 4... 6... 6... 6... 10... 10... 13... 13... 15... 17... 18... 21... 22 23... 23... 23... 24... 28... 30... 32 1 2 2 30 3 4 5 6 biodiversity 7 4 8 9 TV 10 NHK 11 12

ββ 214 215

Microsoft Word - 46流力・ANSS14リーフレット_final.docx

XV-Z10000(J)Ł\1-4.p65

http://www.sharp.co.jp/ 4 2-JW age 2 2..5, :42 2 age 2 2..5, :44 3 age 3 2..5, :44 4 2..5, :44 age 4 5 2..5, :44 age 5 6 2..5, :44 age 6 7 2..5, :44 age 7 8 age 8 2..5, :45 75 76 9 age 9 2..5, :45 4 4

12-7 12-7 12-7 12-7 12-8 12-10 12-10 12-10 12-11 12-12 12-12 12-14 12-15 12-17 12-18 10 12-19 12-20 12-20 12-21 12-22 12-22 12-23 12-25 12-26 12-26 12-29 12-30 12-30 12-31 12-33 12-34 12-3 12-35 12-36

untitled

in 2008/11/24 8020 2 3 4 11 12 35 5 Japan Dental Association 6 7 8 PMTC 9 10 11 12 13 14 Japan Dental Association 15 TNF - α 5mm 20 72 cm 2 TNF - α LPS 16 TNF- LPS TNF-LPS TNF- 17 18 19 20 21 70 22 70

mankantokorodokoro

proposed by seconded by gentlemen! 1 2 3 1 555-3 2 555-3 3 555-4 4 4 555-5 7 1988 63 4 26 1 1971 46 4 1972 47 1 1999 6 20 2004 2 28 http://www.aozora.gr.jp/

21 1113 127 23 21 12 TEL 0762251341 1 44 2 3 20 66 1 6 10 24 36 50 58 80 100 10 104 11 118 12 130 13 144 14 150 15 184 16 186 17 194 18 202 19 204 20 230 21 242 22 254 23 262 24 266 25 268 26 270 271

もえぎ06春49号

w

平成20年度漂流・漂着ゴミに係る国内削減方策モデル調査総括検討会

a b c d a b 69 366 2.9 4.5 a a. b. c. 3 b c d a b c d e a 1340 13 55 15 1355 14 15 14151430 1430 14 35 5 1435 14 50 1450 15 05 15051515 1515 15 35 1535 15 40 20 3 15 15 3 1 15 10 20 5 b c

<4D F736F F D F90858C6E5F C B B B838B>

Isobutyl alcohol IUPAC 2-methylpropan-1-ol 2--1-2-Methyl-1-Propanol, Isobutanol CH 3 H 3 C OH CAS 78-83-1 C 4 H 10 O log P ow ( C) ( C) (kpa) (g/l) 74.12 74.14 1) -108 2) 108 2) 1.2 2) 87 2) 0.8 2) (74.1214)

1

北海道立地質研究所報告第80号

阿部（資料紹介）／阿部

photo by odysseygate 2

photo by odysseygate 1 photo by odysseygate 2 3 4 5 6 photo by odysseygate 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 photo by odysseygate 26 27 photo by odysseygate 28 29 30 31 32 33 34 photo

XF-E211D Telsh-V a e

XF-E211D Telsh-V a e 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 2 3 a 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 4 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 5 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 6 1 2 3 4 5 6

,328 C 6426 H 9900 N 1700 O 2008 S , ,

2458 13 4 24 1 11 9 17 1,328 C 6426 H 9900 N 1700 O 2008 S 44 145,000 148,000 10 11 27 2 13 4 24 11 9 17 (1) CD20 B CD20 (2) infusion reaction infusion-associated symptom CD20 B 1 375mg/m 2 1 4 3 Heavy

PALL NEWS vol.126 November 2017

PALL NEWS November 2017 Vol.126 PALL NEWS vol.126 November 2017 NEW =2000 9660 41.4 MPa 24 MPa NFPA T2.06.01 R2-2001 CAT C/90/* (1x10 6 0-28 MPa 1x10 6 29 120 C 60 C 450 Pa 340 Pa 1 MPa JIS B 8356-3/ISO

1999年3月作成(新様式第１版)　

200622 19989 871313 1mL4mg JAN oxybuprocaine hydrochloridejan 2002621 20037 4 19667 1 FAX 2005 10 29607 05 1 63 () 103 2 3 49 111 4 Drug Safety Update 1. -------------------------------------1 2. -----------------------1

13 13 13 13 M 1000 1001 1002 1003 1004 1005 12 54 67 12 133 5 14 1006 12 71 72 43 186 5 14 1007 1 1008 35-62-1 C 35--62-31 C 35-62-2 B 35-62-32 C 35-62-3 A 35-62-33 C 35-62-4 B 35-62-34 C 35-62-5 C 35-62-35

2005年7月作成(新様式第1版) 　

. - 1 - Magnesium Oxide 250mgTX Magnesium Oxide 330mgTX Try-X Co.,Ltd. Magnesium Oxide [JAN] Magnesium Oxide [JAN] - 2 - - 3 - TX 11 TX 12-4 - - 5 - - 6 - - 7 - - 8 - - 9 - - 10 - - 11 - - 12 - - 13 -

10月表紙BB.indd

Q F Q Q Q Q Q Q Q F QF F QF QF F Q F 三 Q QF Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q P F F F F F F F F QF Q F PNAYQ RX Y F A P P P P Q F P Q F R P Y F Q R QF P QF P A Q F P A F Q P A F A Y F Q P A F P Q F PNAYQ RX

ŁRŁ¸•ñŁŁŁ‘

16 11 5 25mg 14 11 18 1 25mg 1 150,000 934 1 2 : 1-235-tumor necrosis factor receptor (human) fusion protein with 236-467-immunoglobulin G1 (human γ1-chain Fc fragment), dimmer : : 1 235 236 467 G 1 γ1

LCMS14003:UHPLC-Orbitrap質量分析計による環境汚染物質のターゲット分析、ノンターゲット分析

UHPLC Orbitrap Application Note LCMS14003 Orbitrap CEC CEC 61 CEC 312 CEC SPE UHPLCThermo Scientifi c Orbitrap Thermo Scientifi c TraceFinder WWTP S1 PS 5 ºC S2 TWAS 5 ºC 1 WWTP 1 2 WWTP 2 1 2 S1 1 S2

2

(

( 2 3 4 Sx x C 2 C 2 5 6 Arnold Demain: TIBTEC JAUARY 2000) 7 8 2 2 Duocarmycin B2 Mitomicin C Br ES-242-1 RES-1149-1 DC102 DC14E Kaprimycin A1 Staurosporine Manumycin A Clecarmycin wortmannin Saintopin

jscr15-1Net.indd

Vol.15, No.1(2011) JSCR Newsletter JSCR Newsletter published by The Japanese Society of Carbohydrate Research β JSCR Newsletter Vol.15,No.1(2011) 1 2 JSCR Newsletter Vol. 15, No.1 (2011) β α β α JSCR Newsletter

狂牛病調査第２巻1章，２章.doc

21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 2.1 A LD50/30mg () 10 ND 1 2.8 ND ND ND 11 ND 2.3 1.0 ND ND 11 ND ND 1.3 1.7 ND 13 ND

１

10 2 1990 5 1993 6 16 11 24 18 35 1960 41 1966 19 2 11 14 30 1955 10 41 1966 12 16 45 40 35 2004 2004 2004 30 25 20 15 10 5 0 1950 1960 1970 1980 1990 2000 6 10 1 6 46 10 2223 2 6 10 6 10 1 6 7 8 1011

Res. Org. Geochem. 31, 1 17 (2015) 地球 環境有機分子質量分析マニュアル No.29 技術論文 LC/ESI-MS * ** ** ** はじめに Eksborg and Schill, 1973; Gloor and

Res. rg. Geochem. 31, 1 17 (2015) 地球 環境有機分子質量分析マニュアル No.29 技術論文 LC/ESI-MS * ** ** ** 2014 9 16 2014 12 1 1. はじめに Eksborg and Schill, 1973; Gloor and Johnson, 1977; Chaimbault et al., 2000 Knox and Hartwick,

PathScan Antibody Array Kits

athscan Antibody Array Kits athscan Antibody Array Kits athscan Antibody Array CST athscan Antibody Array Nicole, roduct Scientist has beenen at CST for over years. 0 µl (0.-0. mg/ml) athscan RTK Signaling

CD-ROM CD-ROM CD-ROM CD-ROM CD-ROM CD-ROM CD-ROM CD-ROM CD-ROM CD-ROM CD-ROM CD-ROM CD-ROM CD-ROM CD-ROM 4000 ED COOLSCAN IV ED 4000 ED 4000 ED 4000 ED 4000 ED 4000 ED 4000 ED 4000

untitled

... 1... 29... 31... 65 ... 152... 160... 162 ... 169 ... 201 1 2 3 4 玢 5 6 7 8 9 10 11 12 13 14 15 16 17 23 9 28 26 31 18 19 - - T.P.+ 1 21 3 8 22 3 1 18 2 8 41 2 T.P.+m 20 21 22 23 24 25 26 27 28 29

Fig. 1. Structures of NM394, NAD-358 and NAD-245 Fig. 2. Typical HPLC chromatograms of NM394 in human plasma by organic solvent extraction method (a): Blank plasma (b): Plasma spiked with NM394 and internal

1

1 2 3 4 1,000 200 21 63 21 200 5 6 7 8 30 9 10 21 6 9 http://clearing.fsa.go.jp/kashikin/index.php 708 11 54 452 452 454 12 13 14 15 1520 16 17 18 19 20 21 30 60 22 23 221 24 25 26 27 29.2 20% 18% 10 100

11.1_窶ｦ窶懌€ｦV窶ｦA.ec6

Q Q= d 2 V V= 4 d P + H + = 2g W V 2 V m/s g 9.8m/s H () P kgf/s, W Kg/ H= V=2 2 () 3 V 2 (h) ()(L) ()(f) ()(V) 2 ()(d) ()(P) L V 2 h= f d 2-70

() (H) () ( P) () (H)() 1 1,000kg 1 1m 1,000/100x100 0.1kgf/ (H)m=(P)1kgf/ (0.098 (H)m 1 2 3 4 5 6 7 8 9 10 (P)kgf/ 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 1.0 (P) 0.0098 0.0196 0.0294 0.0392 0.0490 0.0588

ｎｓｇ０１－０４／ｋｙ６９５７４９４６０５０００６０１５２

untitled

20 2 14 18 10 16 1 1.0mg 0.035mg 2 1 20 2 14 18 10 16 1 1 1 52 1 1 21 7 28 1 29 2 1 20 1 24 18 10 16 1 1 21 7 28 1 29 1 NET 1.0mg EE 0.035mg *NET *NET 1999 2007 *NET *NET 88 NSAIDs GnRH GnRH NSAIDs 20

PhD HIPAA sports nutrition coach ACE ISSN Sports Nutrition Specialist Certification ISSN CISSN IOC IOC 3

1 9 2017-05-06 Marie Spano, MS, RD 185 AND CSSD 2 9 2017-05-06 PhD HIPAA sports nutrition coach ACE ISSN Sports Nutrition Specialist Certification ISSN CISSN IOC IOC 3 3 136 EPA D 46 B12 B12 B12 2010 98

A.N 59

ANALYTICAL NEWS No.059 2 ANALYTICAL NEWS EM ANALYTICAL NEWS 3 MS 4 ANALYTICAL NEWS ANALYTICAL NEWS 5 NMR EM 6 ANALYTICAL NEWS ANALYTICAL NEWS 7 EM 8 ANALYTICAL NEWS ANALYTICAL NEWS 9 NMR MS Hardware DAWin

SOS

untitled

259 2012 11 21 14 17 BOAZ 1985 9 6 4 20 10 1 8 5 5 2000 8 1 1 1 3 1 1966 45 3km 7 8 9 1971 1976 2 2000 5 1 3 350 3 1 10 34 3 40 25 40 20 40 60 100 20 401 10 4 3 5 1 40 1 7 1 19 34 510 1 1 10 10 1 CSR 10

..............................................................................

.............................................................................. ......................................................................................................... .....................................................................................................................

橡96-07.PDF

1 967 2482 CAS 50000 CH 2 O 30.03 2952% 12.5 % 1. 2) -92 2) -19.5 2) 5085 3) 424 3) 7.073.0% 4) 20 d 4 0.815 5) 1.03 ( = 1) 5) 1.33 kpa (10 mmhg) (-88.0) 2) log Pow0.35 ( ) 6) 0.35 ( ) 7) 1) m/z 29 ( 1.0